Wed, Jul 23, 2014, 11:30 AM EDT - U.S. Markets close in 4 hrs 30 mins

Recent

% | $
Click the to save as a favorite.

Analog Devices, Inc. Message Board

rorystreamer 440 posts  |  Last Activity: Mar 13, 2014 7:50 PM Member since: Mar 11, 2013
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Kudos to Macaluso & team.....

    by superforce_57 Mar 13, 2014 7:40 PM
    rorystreamer rorystreamer Mar 13, 2014 7:50 PM Flag

    Absolutely. Once a few large parties come chopping at the bit, good money will find it. I jumped on $PLUG after the 50% dump in 1 day and rode that for 2 days. Also $ARIA after FDA re-submitted their flagship drug, rode that to $8.50. $AMPE poised to rally to $8 no problem.

    Sentiment: Strong Buy

  • Reply to

    Thoughts on the call?

    by th3k33p3r24 Mar 13, 2014 5:15 PM
    rorystreamer rorystreamer Mar 13, 2014 7:48 PM Flag

    Went better than expected. With trading down all day, some huge blocks being dumped, I really did not know if someone knew something I didn't and others were falling suit. However, its nice to see up 6% AH. Its been a beat down, but now with guidance, almost $100M in bank, no outstanding debt, new facility, contract for serum, FDA submission soon, the company seems confident. Should rally by end of week and above $8 again.

    Sentiment: Strong Buy

  • Reply to

    AMPE CC on Thursday

    by grindle00 Mar 11, 2014 8:34 AM
    rorystreamer rorystreamer Mar 11, 2014 10:59 AM Flag

    The rally starts now.

  • Reply to

    Ampio Did Their Part

    by racavalli Mar 6, 2014 3:26 PM
    rorystreamer rorystreamer Mar 6, 2014 4:59 PM Flag

    The market responded in evaluating $AMPE's PPS, which shows some support in the $7 range and for good reason. They netted $63.3M priced at $7 p/Share. Once some time elapses, you will find a few articles writing about the possibilities of Ampion & Optina, and what they will say is they have a ton of cash and no debt. This happens all the time on the street, it just doesn't affect the long-term shareholder that has conviction in the pipeline and long-term success. I have been trading this company since 2012 and I will continue to acquire more now that this is better positioned. 3 months and shareholders will know. And my colleagues that cover other biotech's, have now chimed in and did some dd on their own, and with their opinions on the company and overall outlook, they anticipate this to rally in anticipation as with most other companies. See $INO, $CTIC, $ARIA, $ONCS. It will happen. As soon as CEO gets more transparent, more interest will spark and all of that will lead to additional volume etc. Good luck to all.

    Sentiment: Strong Buy

  • Ampio today announced the closing of its sale of 9,775,000 shares of common stock in an underwritten public offering. The total number of shares of common stock sold reflects the full exercise by the underwriters of their option to purchase an additional 1,275,000 shares of common stock. As a result, Ampio Pharmaceuticals, Inc. has received gross proceeds of approximately $68 million. Net proceeds, after deducting underwriting discounts and commissions and other estimated fees and expenses payable by Ampio Pharmaceuticals, Inc., will be approximately $63.3 million. Add this to their current cash levels of $26M and that puts this small bitech company from Colorado at around $90M. With 2 blockbuster drugs in the pipeline, Id have to say that this recent offering was well timed and well done. Two known bankers on this offering is always a plus. So much will happen in the next 3 months. This will not be in the $7's for much longer. Been long since $4 and have more evidence come March 2014 that $AMPE is doing all the right things for production of Ampion. Should see a rally soon.

    Sentiment: Strong Buy

  • Reply to

    Predictable

    by th3k33p3r24 Mar 4, 2014 2:26 PM
    rorystreamer rorystreamer Mar 4, 2014 7:59 PM Flag

    The bottom line is $AMPE now has plenty of capital for 2014. They anticipate news relating to Ampion in next 3 months. This earnings call should shed light on current situation. Even though mgmt. hasn't been the most transparent, pieces to the puzzle will come together and hopefully this ends with Ampion getting FDA approval and the PPS increases 40% over night. But as I have watched this trade for a while, this will rally in anticipation. Short interest was up from last month (which is understandable given the latest offering) and that is funny how so many seemed to know for some reason lol. But institutional ownership will continue to grow, new analysts will begin to cover, some firms will establish price targets and print detailed reports and then mass email them, so buzz will pick up. Already $AMPE stated they will be submitting BLA docs around summer time. With being in March 2014 already, if you have paid attention to this company and Ampion/Optina, then you very well know that they have 2 potential blockbuster drugs in the pipeline, 1 nearing the finish line. Now, of course with all my subjective commentary, this could very easily go south in a minute and every shareholder doesn't want to lose 40% of their position overnight. So the conf call should paint a picture, even though it will be different shades of grey, you should still know they raised this money for operational purposes/new facility/manufacturing equipment/Human Serum/Additional employee compensation.. I mean I know wall street gives away millions everyday to loser companies, but $55M isn't a small chunk of change, add that to their current cash levels of $25M include the no debt and you have a well positioned company sitting at $7.50 p/Share which in my mind will be $8.50p/share in a few weeks if not less. Now of course Ukraine and global economic policy, our US data reports and misc market trends and patterns can make it trade sideways, but there is earnings call and that should start the rally

    Sentiment: Strong Buy

  • Reply to

    AMPE IS NOW READY TO BE THE NEXT BIG BIOTECH

    by racavalli Mar 3, 2014 8:32 PM
    rorystreamer rorystreamer Mar 4, 2014 10:53 AM Flag

    They are positioned well financially. Next earnings call will be huge

    Sentiment: Strong Buy

  • rorystreamer rorystreamer Feb 27, 2014 3:55 PM Flag

    Yes you will see near-term PPS adjustments that will correlate with market conditions & current price offering, however look at the big picture as we near completion of FDA approval for Ampion and the earnings call in a few weeks, CEO should provide more color on current situation. Plus, at the end of the day in 3 months, they should have $26M + lets say $70M from recent shelf offering, close to $100M minus quarterly operating costs, still hovering around $80M in the bank before BLA docs submitted for approval. At least they can get financing. And having capital on hand has always been a major factor. Lets say this gets approved, they look good on paper. Its all speculation, but I would anticipate interest going in the 1st week of March and it should bounce back. Just a thought. Good luck.

    Sentiment: Strong Buy

  • Reply to

    Look at what could happen to Ampio!

    by agnewpeters Feb 25, 2014 9:34 AM
    rorystreamer rorystreamer Feb 26, 2014 8:41 PM Flag

    Any comparison is irrelevant. However, the upside is tremendous. I initially bought in around $4 and increased over time. So I will cash out if needed. Yet, I like following these companies $INO and $CTIC, when its trading near nothing ($0.75 $ $1.50 respectively) then news hits and they pop 30% its for good reason. Now 3 months look at them, all trading in the $3's. $Kerx, another example, news hits this goes to $12, drops to low $8's and then pops to $15. Its realizing the initial pop and playing off it. With $AMPE there is just a steady incline with news on the horizon that could very well see 50% if FDA approved. So that will bring $AMPE up to $12 and then in 8 months, this will trade at $16 once market cap is established etc. Its all hypothetical, yet like other companies mentioned if good news hits, if good money is there, just sit back and enjoy the ride. And of course, always be on the look out for possible red flags and then sit on the sidelines until your questions are answered and buy right back in. Its a game of luck w. Biotechs, you just never know.

    Sentiment: Buy

  • Reply to

    Share price prediction

    by safetyman41 Feb 26, 2014 12:58 AM
    rorystreamer rorystreamer Feb 26, 2014 8:32 PM Flag

    Making this statement w/out reasoning likely determines your age and experience. If you are invested in this company, there is good reason. There will always be the other side of the argument that you cant ignore, but you base your facts on the pros and cons and pick one. If you day trade, then making comments like that is quite normal. You can back it up saying my chart signals this and because this trended along side the 50mda then this will happen. But you aren't technical. And your not an analyst. And obviously you aren't the CFO or COO of a small-medium size company, merely bc your writing on a Yahoo board. So realistically what are you bringing to the table? A whole lot of nothing. So just bc Agnew is yelling from the rooftops at least he is committed and is trying to read anything and everything that is being published relating to $AMPE. You on the other hand is affected by this somehow and in some random shape or form you came up with Todays stock price of $8, so you missed that by $0.45. Thursday around $7.70. So you need $AMPE to drop $0.75 in 2 days. And Friday you need $AMPE to drop an additional $0.40. After the announcement to offer 8M shares, price undisclosed but most think $8.50, which again will bring in $70M respectively, you believe that this will drop that much. With institutional ownership at 41%, two big names on the offering, I would expect more interest and possible large stakes to start some manipulation/ momentum and this stock rallies until summer exceeding $10 no problem. Now, everything is subject to BLA docs and moving forward with Ampion. So it could very well be delayed and dropped 30% on the news. That is something everyone should be aware of. But play the rally, make some money. We are all retail investors trying to make a buck. Good Luck

    Sentiment: Strong Buy

  • Reply to

    AMPE about to go mainstream....

    by superforce_57 Feb 24, 2014 6:52 PM
    rorystreamer rorystreamer Feb 24, 2014 7:36 PM Flag

    We knew that $AMPE would eventually raise more capital. Today they announced to offer 8,000,000 shares of its common stock in a proposed underwritten public offering with the price undisclosed. However with roughly $26M in the bank, this was inevitable. The fact is if $AMPE had done this with $12M in the bank, there should be uncertainty in why they waited so long. But they didn't. And I am not saying dilution is a good thing, however 8,000,000 shares is a descent offering and should provide enough capital moving forward. Summer time is when they submit BLA docs and we CEO should provide more color in early march when they announce earnings.

    This company has not made money, in fact all they have done is raise it. But as Citigroup Global Markets Inc. and Jefferies LLC are acting as joint book-running managers for the offering, this is better than a company like $HTGC. So there is potential near-term downside with no news, or as more interest is focused on the (2) pipeline winners, this could very easily rally. Institutional ownership is at 41% so good things to come. This should be interesting. Glad to see some big names associated with $AMPE. If there is money to be made, investors will find it period.

    Sentiment: Strong Buy

  • Reply to

    near term opportunity

    by stevemrrtt Feb 19, 2014 12:39 PM
    rorystreamer rorystreamer Feb 21, 2014 7:01 PM Flag

    The disconnect lies with long-term shareholders and day traders or swing traders or combinations of both. However, in $AMPE's argument and its been the same since trading at $4 bucks 52-Weeks ago (minus Zertane) is the success of Ampion & Optina and 2014 being a crucial year for this company. To be honest, yes there isn't a big banker hence why $AMPE is up 5.15% on 447,913 volume, a nice $0.44 gain btw. But they had $32M in the bank 3 months ago, spent some dough on a 10yr lease in Downtown Denver, contracted a sale agreement for the serum, put together a $100M mixed shelf etc... descent timeline of events leading up to summer 2014, all signs of good faith that the company feels confident the FDA will approve. Now with Biotech companies, nothing is a lock. It should definitely rally in anticipation, and regardless we are all here to make money. Making stock calls are hard to do, hence why smart ones don't. But a 14% gain is good. Short interest is still high, volumes are low, usually it trades off a few big morning Sellers or like today a few big morning buyers. Its very easy to see how this goes up and down.

    Sentiment: Buy

  • Reply to

    Held at major support and now seeking new highs

    by racavalli Feb 21, 2014 1:57 PM
    rorystreamer rorystreamer Feb 21, 2014 2:58 PM Flag

    I agree. These are better versions of the originals, both Optina & Ampion. $AMPE to begin production in new facility by summer. Hiring additional personnel to operate production runs. Expect a big rally and test 52-week highs. By summer this should trade above $10 given more indication on BLA submission and progress not published. And of course anything that comes out that negates my thesis, I will take my profits off the table and see what happens. FDA approval sends the PPS to $14 easy. The time frame is 3-5 months. Should be interesting to see.

    Sentiment: Buy

  • Reply to

    AMPIO WILL TRADE AT $200 A SHARE!

    by agnewpeters Feb 21, 2014 11:22 AM
    rorystreamer rorystreamer Feb 21, 2014 12:54 PM Flag

    $AMPE is not reinventing the wheel, simply changing the application. $AMPE $ARNA $INO $CTIC $ARRY $MACK all working for me today gotta love it before the weekend

    Sentiment: Buy

  • rorystreamer by rorystreamer Feb 21, 2014 11:53 AM Flag

    Great morning as we needed some action. Short interest is still decent so this could very well close above $9

    Sentiment: Buy

  • Reply to

    STEP Enrollment Completion

    by billwilliams836 Feb 18, 2014 10:55 AM
    rorystreamer rorystreamer Feb 18, 2014 12:12 PM Flag

    I really like the fact that Macaluso said "The manufacturing facility is expected to begin production of test batches of Ampion™ early this summer." Once its official, this will soar. But looking at the glass 1/2 empty, for so many reasons the FDA can delay and require more testing. So we can also anticipate some more fluff if this were to happen. All in all this is good news. I would expect another huge spike around 10am pst and then this closes above $9 today.

    Sentiment: Strong Buy

  • Reply to

    STEP Enrollment Completion

    by billwilliams836 Feb 18, 2014 10:55 AM
    rorystreamer rorystreamer Feb 18, 2014 11:03 AM Flag

    I think that the BOD & CEO have an agenda and that agenda unfortunately has nothing to do with shareholders in mind. With that said, neither do most publicly traded companies. However, $AMPE amongst other biotech's, its about putting the pieces together and looking at the whole picture. Looking at the timeline of events starting in 2012 it seems that what they have done thus far has worked. But now the timeline of events has some critical milestones approaching. As you know they are planning on submitting BLA docs most likely August or September, which means that the FDA approval comes before that and the PPS will increase 30% and then gradually over time triple. Now as any investor knows nothing is a guarantee and looking at the argument against $AMPE, there are things you should be concerned about. So with everything in mind, I have been a shareholder long term since 2012 and initially got in around the $4 range. I do think that they get approved and it will be trading north of $13 in anticipation of the approval, so a nice rally should ensue in weeks to come. Good luck $AMPE longs.

    Sentiment: Strong Buy

  • rorystreamer rorystreamer Feb 13, 2014 4:46 PM Flag

    Typically the news will translate into gains tomorrow. In the case with $AMPE (Last 18 months of trading), most of the positive publications seem to transpire the day after. It may be because $AMPE is not on most radars. To state the obvious, no big banker has always equated to low or no volume for biotechs like $AMPE. I do like to see it up 1.81% on 321,897 volume tho. However, when FDA approves Ampion this will trade volume 15M-20M where most shareholders feel they need it to be. So between Feb 2014 to August 2014, there should be significant interest in the approval. So expect a run up in PPS from now till then. This should be trading above $10 in months to come. Any positive news speeds this up. Potentially a cash cow.

    Sentiment: Strong Buy

  • rorystreamer by rorystreamer Feb 13, 2014 2:03 PM Flag

    Watch a few big trades spike this up again and finish strong. Lunch is over, just need a rally to stay above $9 today

    Sentiment: Strong Buy

  • rorystreamer by rorystreamer Feb 13, 2014 2:03 PM Flag

    Watch a few big trades spike this up again and finish strong. Lunch is over, just need a rally to stay above $9 today

    Sentiment: Strong Buy

ADI
52.11-1.64(-3.05%)11:30 AMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.